On 2024-05-02, Dyne Therapeutics, Inc. (DYN) announced earnings per share of $-0.81 for the fiscal quarter ending 2024-03-31, meeting the average analyst estimate of $-0.81.
The next expected annoucement date for quarterly earnings is 2024-08-01, with an average estimated earnings per share of $-0.74 for the fiscal quarter ending 2024-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-05-02 | 2024-03-31 | $-0.81 | $-0.81 |
| 2024-03-05 | 2023-12-31 | $-0.92 | $-1.09 |
| 2023-10-30 | 2023-09-30 | $-0.86 | $-0.99 |
| 2023-08-03 | 2023-06-30 | $-0.81 | $-1.08 |
| 2023-05-11 | 2023-03-31 | $-0.77 | $-0.78 |
| 2023-03-02 | 2022-12-31 | $-0.84 | $-0.74 |
| 2022-11-03 | 2022-09-30 | $-0.95 | $-0.80 |
| 2022-08-04 | 2022-06-30 | $-0.79 | $-1.01 |
| 2022-05-02 | 2022-03-31 | $-0.88 | $-0.69 |
| 2022-03-10 | 2021-12-31 | $-0.99 | $-1.00 |
| 2021-11-04 | 2021-09-30 | $-0.65 | $-0.83 |
| 2021-08-05 | 2021-06-30 | $-0.55 | $-0.58 |
| 2021-05-06 | 2021-03-31 | $-0.60 | $-0.50 |
| 2021-03-04 | 2020-12-31 | $-0.38 | $-0.64 |
| 2020-11-05 | 2020-09-30 | $-0.88 | $-2.01 |